(27 days)
Not Found
No
The provided text describes a mechanical balloon catheter and does not mention any AI or ML components or functionalities.
Yes
The device is used for Percutaneous Transluminal Angioplasty (PTA) to treat obstructive lesions in peripheral vasculature and dialysis fistulae, which is a therapeutic medical intervention.
No
This device is a therapeutic device (balloon dilatation catheter) used for Percutaneous Transluminal Angioplasty (PTA), not for diagnosing conditions.
No
The device description clearly details a physical balloon catheter with a dual lumen shaft, guidewire lumen, balloon lumen, Y-connector manifold, luer lock fittings, radiopaque markerbands, and a coating. These are all hardware components.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. These tests are performed outside of the body.
- Device Description and Intended Use: The Gladiator Balloon Dilatation Catheter is a physical device used inside the body during a medical procedure (Percutaneous Transluminal Angioplasty). It is used to mechanically dilate blood vessels and treat blockages. It does not perform any tests on samples taken from the body.
The information provided clearly describes a therapeutic device used for a medical intervention, not a diagnostic test performed on a sample.
N/A
Intended Use / Indications for Use
The Gladiator Balloon Dilatation Catheter is indicated for Percutaneous Transluminal Angioplasty (PTA) in the peripheral vasculature, including iliac, femoral, popliteal, tibial, peroneal, subclavian, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
The Gladiator Balloon Dilatation Catheter is also indicated for post-dilatation of balloon expandable and self-expanding stents in the peripheral vasculature.
Product codes (comma separated list FDA assigned to the subject device)
LIT, DQY
Device Description
The Boston Scientific Gladiator™ Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter is an Over-the-Wire (OTW) balloon catheter with a dual lumen shaft design. One lumen marked "WIRE" is used to pass the catheter over 0.035" (0.89mm) guidewires. The second lumen marked "BALLOON" communicates with the balloon and is used to inflate and deflate the balloon during the procedure. The guidewire lumen and the balloon lumen terminate at the proximal end of the catheter in a Y-connector manifold with luer lock fittings. There are two radiopaque markerbands located under the balloon shoulders to aid in positioning the system during the procedure. A coating is applied to the balloon to enhance insertion and withdrawal performance. The tip of the catheter is gradually tapered to facilitate advancement of the catheter through the stenosis.
· The Gladiator Balloon Dilatation Catheter will be available with balloon diameters 3.0 mm to 12.0 mm, balloon lengths 20 mm to 100 mm, and with shaft lengths of 40 cm and 75 cm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
peripheral vasculature, including iliac, femoral, popliteal, tibial, peroneal, subclavian, and renal arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biocompatibility testing, bench testing, and sterilization were performed to support a determination of substantial equivalence. The results of these tests provide reasonable assurance that the proposed device has been designed and tested to assure conformance to the requirements for its intended use. No new safety or performance issues were raised during testing.
The following biocompatibility tests were completed on the Gladiator PTA Balloon Dilatation Catheter:
- MEM Elution Cytotoxicity o
- 0 Guinea Pig Maximization Sensitization
- 0 Intracutaneous Reactivity
- Acute Systemic Toxicity 0
- Materials Mediated Rabbit Pyrogen o
- Bacterial Mutagenicity (Ames Assay) 0
- Mouse Lymphoma Assay 0
- Hemolysis Direct Contact and Extract O
- Partial Thromboplastin Time O
- In Vitro Hemocompatibility Assay 0
- Complement Activation 0
- USP Physicochemical O
- Natural Rubber Latex 0
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Mustang PTA Balloon Dilatation Catheters (K103751)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
JAN 1 1 2012
510(k) Summary
| Submitter | Boston Scientific Corporation
One Scimed Place Maple Grove, MN 55311 |
|-----------------------|-------------------------------------------------------------------------|
| Contact Person | Amber R. Johnson |
| Phone Number | 763-494-2643 |
| Fax Number | 763-494-2222 |
| Date Prepared | December 14, 2011 |
| Device Trade Name | Gladiator PTA Balloon Dilatation Catheters |
| Common Name | Percutaneous Transluminal Angioplasty Dilatation Catheter |
| Device Classification | Class II 21 CFR 870.1250 Product Code: LIT, DQY |
Predicate Device
Mustang PTA Balloon Dilatation Catheters
Device Description
The Boston Scientific Gladiator™ Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter is an Over-the-Wire (OTW) balloon catheter with a dual lumen shaft design. One lumen marked "WIRE" is used to pass the catheter over 0.035" (0.89mm) guidewires. The second lumen marked "BALLOON" communicates with the balloon and is used to inflate and deflate the balloon during the procedure. The guidewire lumen and the balloon lumen terminate at the proximal end of the catheter in a Y-connector manifold with luer lock fittings. There are two radiopaque markerbands located under the balloon shoulders to aid in positioning the system during the procedure. A coating is applied to the balloon to enhance insertion and withdrawal performance. The tip of the catheter is gradually tapered to facilitate advancement of the catheter through the stenosis.
· The Gladiator Balloon Dilatation Catheter will be available with balloon diameters 3.0 mm to 12.0 mm, balloon lengths 20 mm to 100 mm, and with shaft lengths of 40 cm and 75 cm.
Indications for Use
The Gladiator Balloon Dilatation Catheter is indicated for Percutaneous Transluminal Angioplasty (PTA) in the peripheral vasculature, including iliac, femoral, popliteal, tibial, peroneal, subclavian, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
The Gladiator Balloon Dilatation Catheter is also indicated for post-dilatation of balloon expandable and self-expanding stents in the peripheral vasculature.
1
Substantial Equivalence
The Gladiator PTA Balloon Dilatation Catheters design, materials, and intended use are substantially equivalent to the predicate device Mustang PTA Balloon Dilatation Catheters (K103751).
Comparison of Technological Characteristics
The Gladiator PTA Balloon Dilatation Catheter incorporates substantially equivalent device design and materials, packaging design and materials, fundamental technology, sterilization processes and intended use as those featured in the Boston Scientific predicate device Mustang PTA Balloon Dilatation Catheters (K103751).
| Characteristic | Mustang predicate |
|---|---|
| Manifold Hub | Same material. Different colorant/additive. Same design |
| serving same function. | |
| Bumper Tip | Same material. Different colorant. Same design serving |
| same function. | |
| Strain Relief | Same material. Same design serving same function. |
| Proximal Dual Lumen Shaft | Same material. Same design serving same function. |
| Proximal Shaft Outer Diameter | Same shaft outer diameters. |
| Balloon | Same balloon material. Same design serving same |
| function and fundamental technology. | |
| Balloon Protector | Same material and similar design serving same function. |
| Pinch-off Tube | Same material. Same design serving same function. |
| Markerbands | Same component serving same function. |
| Coating | Same coating serving same function. |
| Packaging Design | Similar design serving same function. Same carrier tube |
| materials. Different configuration. | |
| Sterilization Method | Same method. |
| SAL | Same level of assurance. |
| Lumens | Same lumens serving same function. |
| Recommended Guidewire | Same compatibility. |
| Balloon Diameters | Same balloon diameter serving same function. |
| Balloon Lengths | Within range of predicate serving same function. |
| Effective Length | Within range of predicate serving same function. |
| Rated Burst Pressure (RBP) | Same Rated Burst Pressure (RBP). |
Comparison to Predicate Device
2
Performance Data
Biocompatibility testing, bench testing, and sterilization were performed to support a determination of substantial equivalence. The results of these tests provide reasonable assurance that the proposed device has been designed and tested to assure conformance to the requirements for its intended use. No new safety or performance issues were raised during testing.
The following biocompatibility tests were completed on the Gladiator PTA Balloon Dilatation Catheter:
- MEM Elution Cytotoxicity o
- 0 Guinea Pig Maximization Sensitization
- 0 Intracutaneous Reactivity
- Acute Systemic Toxicity 0
- Materials Mediated Rabbit Pyrogen o
- Bacterial Mutagenicity (Ames Assay) 0
- Mouse Lymphoma Assay 0
- Hemolysis Direct Contact and Extract O
- Partial Thromboplastin Time O
- In Vitro Hemocompatibility Assay 0
- Complement Activation 0
- USP Physicochemical O
- Natural Rubber Latex 0
Conclusion:
Based on the indications for use, technological characteristics, safety and performance testing, the Gladiator Balloon Dilatation Catheter has been shown to be appropriate for its intended use and is considered to be substantially equivalent to the Boston Scientific Mustang Balloon Dilatation Catheters (K103751).
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol, with three curved lines representing the body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the bird symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JAN 1 1 2012
Boston Scientific c/o Ms. Amber Johnson One Scimed Place Maple Grove, MN 55311
Re: K113681
Trade/Device Name: Gladiator Balloon Dilatation PTA Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II (two) Product Code: LIT, DQY Dated: December 14, 2011 Received: December 15, 2011
Dear Ms. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Amber Johnson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
M. A. Killebrew
്ലം Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use Statement
: :
| 510(k) Number
| (if known) | K113681 | ||
|---|---|---|---|
| Device Name | Gladiator™ PTA Balloon Dilatation Catheters | ||
| Indications for | |||
| Use | The Gladiator Balloon Dilatation Catheter is indicated for | ||
| Percutaneous Transluminal Angioplasty (PTA) in the peripheral | |||
| vasculature, including iliac, femoral, popliteal, tibial, peroneal, | |||
| subclavian, and renal arteries and for the treatment of obstructive | |||
| lesions of native or synthetic arteriovenous dialysis fistulae. |
The Gladiator Balloon Dilatation Catheter is also indicated for post-
dilatation of balloon expandable and self-expanding stents in the
peripheral vasculature. | | |
| Prescription Use X
(Per 21 CFR 801 Subpart D) | | AND/OR | Over-The-Counter Use_
(Per 21 CFR 801 Subpart C) |
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
MI Allehen (Division Sign-Off) Division of Cardiovascular Devices
510(k) Number_K11 368 l